Can peptides help after surgery? What the studies and surgeons say

What is being promised

Recovery from surgery is a natural target for peptide marketing. Wounds have to close, bones have to knit, tendons and ligaments repaired in theatre take months to mature, and people want to get back to work and sport sooner. Online sellers and some clinics offer BPC-157, TB-500 and blends as 'post-op' protocols, citing animal studies of faster healing. The question for anyone facing an operation is simpler: has any of this been tested in people recovering from surgery, and what are the risks of trying it?

Why healing after surgery is hard to speed up

Healing after an operation follows stages that take time whatever is added: bleeding stops and inflammation clears debris in the first days, new tissue and blood vessels form over weeks, and the new tissue is remodelled and strengthened over months. A skin incision regains much of its strength within weeks, but a repaired tendon or a reconstructed ligament is still maturing a year later, and bone takes weeks to bridge and months to remodel. Factors such as smoking, poorly controlled diabetes, poor nutrition and infection slow these stages, and correcting them is where most of the proven gains lie. A product that promised to compress biology measured in months into weeks would need strong evidence, and for the peptides most marketed for recovery that evidence does not exist in people.

What has actually been tested

Ranked by the most relevant human evidence we could find, as of October 3, 2026. Grades come from our encyclopedia and follow the rubric on our methodology page.

Bone: teriparatide, an approved drug with mixed results

Teriparatide, a fragment of parathyroid hormone, is approved for osteoporosis, and animal studies suggested it could speed fracture repair. The test in people was a randomised, double-blind trial in 102 postmenopausal women with wrist fractures treated without surgery, given placebo or one of two teriparatide doses for eight weeks. The median time to bridging of the fracture on X-ray was 9.1 weeks on placebo, 7.4 weeks on the lower dose and 8.8 weeks on the higher dose. The trial's primary comparison, the higher dose against placebo, was not significant; the lower dose's faster healing came from a post hoc analysis that the authors said should be interpreted with caution ¹.

Later trials have added to the picture. A 2026 systematic review and meta-analysis of anti-osteoporosis drugs and fracture healing, covering 28 trials and 5,085 patients, found that teriparatide significantly shortened time to fracture union compared with control, with no significant difference in delayed union rates; bisphosphonates did not change time to union ². Teriparatide is not approved to speed fracture healing, and whether it is used after a fracture or orthopaedic surgery is a decision for the treating surgeon. Our teriparatide entry covers its approved uses and label warnings.

Tendons and ligaments: collagen supplements, not injections

After tendon and ligament surgery, the most-studied peptide product is oral collagen. A 2026 systematic review found randomised trials of collagen-based supplements after anterior cruciate ligament reconstruction and after rotator cuff repair, with improvements in pain, function or imaging; but most products contained several ingredients, and the authors called the signal cautiously positive, as an add-on to rehabilitation ³. Our ranking of peptides for tendon and ligament injuries sets out the wider evidence, including how little exists for BPC-157 and TB-500.

Skin and wounds: a copper peptide cream and a protein in trials

The clearest post-procedure evidence for a cosmetic peptide is small. After carbon dioxide laser resurfacing, patients using a copper tripeptide cream rated their skin quality higher, but the investigators' own measures of healing did not differ between groups ⁴. Thymosin beta-4, the protein TB-500 is based on, has been tested as a topical treatment for chronic venous leg ulcers in a multicentre, placebo-controlled, dose-escalation trial designed to assess safety and healing ⁵; it has not been approved for any wound, and leg ulcers are not surgical incisions.

BPC-157 and TB-500: no surgical studies in people

The two peptides most sold for recovery have not been studied in people after surgery. BPC-157's human record is a two-person intravenous safety pilot ⁶ and an uncontrolled chart review of knee injections in 16 patients ⁷; a 2025 orthopaedic systematic review found 35 of its 36 studies were preclinical ⁸. TB-500 has no human study at all. The closest thing to a surgical model is a 2026 rat study in which repaired Achilles tendons were treated with BPC-157, TB-500, both or nothing for four weeks: only TB-500 alone produced a significant gain in tendon strength, and BPC-157 alone did not reach significance on the overall scores ⁹. Animal studies of faster healing are a reason to run trials, not evidence that the peptides help people recover from operations. Both are prohibited by WADA, neither is FDA-approved, and FDA had not acted on its advisory committee's July 2026 recommendation to allow their compounding as of October 3, 2026.

What surgeons worry about

Surgeons and anaesthetists raise several concerns about patients using unregulated peptides around an operation. The first is simply not knowing: products bought online may not contain what the label says, and nobody has studied how BPC-157, TB-500 or most other research peptides interact with anaesthetic drugs, antibiotics, blood thinners or the medicines given after surgery. Our Interaction Matrix shows how much has been reviewed for each peptide, and for most research peptides the honest answer is that little is known.

The second is biological. BPC-157 is promoted partly for promoting blood vessel growth, and that raises questions for people with a history of cancer; our article on BPC-157 and angiogenesis sets out what is and is not known. Injections near a surgical site add infection risk, especially with products not made to sterile pharmaceutical standards.

The third is specific and well documented. GLP-1 drugs, including semaglutide and tirzepatide, slow stomach emptying, and their labels warn of rare cases of food being inhaled into the lungs under general anaesthesia or deep sedation, telling patients to inform their healthcare providers of any planned procedure ¹⁰. Our guide to GLP-1s before surgery covers the current guidance, which no longer advises stopping for most patients but does ask the team to know.

Clinic and telehealth 'recovery protocols'

Some anti-ageing clinics and telehealth services now offer peptide 'recovery protocols' around surgery, often presented as more legitimate than buying online. The regulatory status does not change because a clinic is involved. BPC-157 and TB-500 are not FDA-approved, and as of October 3, 2026 FDA had not acted on its advisory committee's July 2026 vote, so pharmacies could not lawfully compound them. Products labelled 'for research use only' are not made or tested for people at all. If a clinic offers a peptide around your operation, ask what exactly it is, who made it, whether it comes from a licensed pharmacy, and whether your surgeon knows. A clinic that will not answer those questions is telling you something.

Questions to take to your pre-operative appointment

• I take these peptides or supplements (name, amount, last dose). Should I stop any of them before surgery, and when?
• Could any of them affect anaesthesia, bleeding, infection risk or the medicines I will be given afterwards?
• I take a GLP-1 drug for diabetes or weight. Do you want me to change anything, such as following a liquid diet the day before?
• When is it safe to restart anything I stop?
• For bone or orthopaedic surgery: is there anything with real evidence, such as osteoporosis treatment or a rehabilitation plan, that I should be doing?

Tell your team: disclosure matters

Many people use supplements and other products before surgery without mentioning them. In a US survey of elective surgical patients at 16 hospitals, 67% reported using complementary products in the two weeks before surgery, including herbs, supplements and vitamins, and 34% used products that could potentially interact with anaesthetics or interfere with blood clotting ¹¹. That survey predates the peptide boom, but the lesson applies: your anaesthetist and surgeon can only plan around what they know.

Before any operation, tell the team exactly what you take, including research peptides, compounded products and anything injected, with the product name, the amount and when you last used it. Bring the vial or label if you can. Ask whether anything should be stopped and when it is safe to restart. Do not stop a prescribed medicine on your own, and do not start a new peptide around surgery without discussing it.

What does help recovery

The things with evidence behind them are less exciting: following the surgical team's instructions on wound care and activity, early mobilisation when advised, structured rehabilitation for orthopaedic operations, enough protein and calories, not smoking, controlling blood sugar in diabetes, and attending follow-up. For bone, the surgeon may consider treatment for osteoporosis, which is where teriparatide's evidence fits. None of these is a peptide, and none is sold with a promise of halving recovery time.

Frequently asked questions

What are the best peptides for post-surgery recovery?

No peptide is approved to speed surgical recovery. Teriparatide has mixed evidence in fracture healing, and collagen supplements a cautiously positive signal after ligament and rotator cuff repair. BPC-157 and TB-500 have no human surgical studies.

Can I take BPC-157 after surgery?

It has not been tested in people recovering from surgery, it is not FDA-approved, and its interactions with anaesthetic and post-operative drugs are unknown. Discuss anything you plan to take with your surgical team.

Should I tell my surgeon about peptides?

Yes. Tell your surgeon and anaesthetist about every peptide, supplement and compounded product you use, with the amount and when you last took it, and ask what to stop and when to restart.

Do I need to stop Ozempic or Wegovy before surgery?

Not necessarily. Since 2024 most guidance says many patients can continue, with extra precautions for those at higher risk. The labels ask you to tell your healthcare providers about any planned procedure.

Related on Grey Peptides

• Teriparatide
• BPC-157
• GLP-1s before surgery

Sources

1. Aspenberg, P., et al. (2010). Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res, 25(2), 404-14. PMID: 19594305
2. Agarwal, N., et al. (2026). The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis. Lancet Healthy Longev, 7(5), 100827. PMID: 42229491
3. Latini, L., et al. (2026). Clinical evidence for low-molecular-weight collagen peptides in tendon and ligament tears: a systematic review with narrative synthesis. Front Med (Lausanne), 13, 1891011. PMID: 42666580
4. Miller, T. R., et al. (2006). Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg, 8(4), 252-9. PMID: 16847171
5. Guarnera, G., et al. (2007). Thymosin beta-4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing. Ann N Y Acad Sci, 1112, 407-12. PMID: 17495250
6. Lee, E., et al. (2025). Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med, 31(5), 20-24. PMID: 40131143
7. Lee, E., et al. (2021). Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med, 27(4), 8-13. PMID: 34324435
8. Vasireddi, N., et al. (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J, 21(4), 485-495. PMID: 40756949
9. Biçer, O., et al. (2026). Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study. Jt Dis Relat Surg, 37(3), 822-837. PMID: 42542926
10. Novo Nordisk. Wegovy (semaglutide) US prescribing information, section 5.10 Pulmonary Aspiration During General Anesthesia or Deep Sedation (DailyMed set ee06186f, effective June 18, 2026); read October 3, 2026.
11. Norred, C. L. (2002). Complementary and alternative medicine use by surgical patients. AORN J, 76(6), 1013-21. PMID: 12528489

Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.